CS logo
small CS logo
Oulu Mentalcare Oy

Oulu, Finland
Mental health service in Oulu
Heikinkatu 7, 90100 Oulu

About Oulu Mentalcare Oy


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
ACADIA Pharmaceuticals Inc.
2
Janssen Research & Development, LLC
2
Boehringer Ingelheim
1
Minerva Neurosciences
1
Total Rows: 5

Clinical Trials at Oulu Mentalcare Oy


During the past decade, Oulu Mentalcare Oy conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11112211110022001111Started TrialsCompleted Trails201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.
2012-05-01
2015-07-01
Completed
4,595
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
2017-08-16
2019-01-19
Completed
287
A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder
2018-03-30
2019-12-13
Completed
360
Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
2019-04-25
2020-05-29
Completed
298
Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
2019-06-06
2021-02-22
Terminated
235
A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
2020-09-15
2022-07-14
Terminated
212

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Oulu Mentalcare Oy" #1 sponsor was "Pfizer" with 3 trials, followed by "ACADIA Pharmaceuticals Inc." with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Minerva Neurosciences" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 3Pfizer: 3ACADIA Pharmaceuticals Inc.: 2ACADIA Pharmaceuticals Inc.: 2Janssen Research &Development, LLC: 2Janssen Research &Development, LLC: 2Boehringer Ingelheim: 1Boehringer Ingelheim: 1Minerva Neurosciences: 1Minerva Neurosciences: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Oulu Mentalcare Oy


According to Clinical.Site data, the most researched conditions in "Oulu Mentalcare Oy" are "Adjunctive Treatment of Major Depressive Disorder" (2 trials), "Cardiovascular Disease" (2 trials), "Depressive Disorder, Major" (2 trials), "Major Depressive Disorder" (1 trials) and "Post-Traumatic Stress Disorder" (1 trials). Many other conditions were trialed in "Oulu Mentalcare Oy" in a lesser frequency.

Clinical Trials Intervention Types at Oulu Mentalcare Oy


Most popular intervention types in "Oulu Mentalcare Oy" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Pimavanserin" (2 trials), "bococizumab (PF-04950615)" (2 trials), "BI 1358894" (1 trials) and "JNJ-42847922" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Oulu Mentalcare Oy


The vast majority of trials in "Oulu Mentalcare Oy" are 9 trials for "All" genders.

Clinical Trials Status at Oulu Mentalcare Oy


Currently, there are NaN active trials in "Oulu Mentalcare Oy". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Oulu Mentalcare Oy, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Oulu Mentalcare Oy, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Phase 2: 3Phase 2: 3Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4Terminated: 4Terminated: 4Recruiting: 1Recruiting: 1